Sanara MedTech (SMTI) EGM 2026 summary
Event summary combining transcript, slides, and related documents.
EGM 2026 summary
30 Sep, 2026Opening remarks and agenda
Meeting called to order by the CEO, welcoming shareholders and outlining virtual participation procedures.
Chairman and Secretary roles designated; Inspector of Elections appointed.
Agenda includes voting on merger, advisory compensation, and potential adjournment.
Specific resolutions to be voted on
Approval and adoption of the merger agreement with MiMedx and Mustang Merger Sub.
Advisory vote on compensation for named executive officers related to the merger.
Approval of adjournment if more time is needed to solicit proxies.
Overview of voting outcomes
Quorum confirmed with over 50% of shares represented.
Merger proposal approved by majority of shares present or represented by proxy.
Advisory compensation proposal also approved by majority vote.
Adjournment proposal not required as sufficient votes were received.
Final voting results to be filed in Form 8-K within four business days.
Latest events from Sanara MedTech
- Sanara shareholders to receive cash and stock in a premium merger with MiMedx, pending approvals.SMTI
Proxy filing - Q2 2026 revenue rose 9% to $28.1M with a 93% gross margin and a merger deal with MiMedx announced.SMTI
Q2 2026 - Record revenue and high margins reflect a focused, innovation-driven surgical solutions strategy.SMTI
Investor presentation - All proposals passed, including director elections, auditor ratification, and compensation approvals.SMTI
AGM 2026 - Focused on surgical wound care, the company projects strong growth and new product launches.SMTI
TD Cowen 46th Annual Health Care Conference - Q1 2026 revenue rose 19% to $27.8M, with net income of $0.4M and strong gross margin of 93%.SMTI
Q1 2026 - New Lead Independent Director and Compensation Committee chair appointed, with updated compensation.SMTI
Proxy filing - Strong Q2 growth, expanded leadership, and a robust product pipeline position the company for future success.SMTI
Cantor Global Healthcare Conference 2025 - Q1 2025 revenue up 26% to $23.4M, margin and EBITDA gains, net loss widens, cash at $20.7M.SMTI
Q1 2025